Smith, Salley & Associates Boston Scientific Corp Transaction History

Smith, Salley & Associates

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 24, 2020	SELL	$25.83 - $45.71 $153,972 - $272,477	-5,961 Closed	0 $0
Q3 2019 Oct 30, 2019	SELL	$40.31 - $43.45 $9,674 - $10,428	-240 Reduced 3.87%	5,961 $243,000
Q2 2019 Jul 12, 2019	SELL	$34.91 - $42.98 $1,047 - $1,289	-30 Reduced 0.48%	6,201 $267,000
Q1 2019 May 03, 2019	SELL	$32.91 - $40.75 $35,871 - $44,417	-1,090 Reduced 14.89%	6,231 $239,000
Q4 2018 Feb 05, 2019	SELL	$31.73 - $39.04 $43,660 - $53,719	-1,376 Reduced 15.82%	7,321 $259,000
Q3 2018 Nov 06, 2018	BUY	$32.83 - $38.63 $1,346 - $1,583	41 Added 0.47%	8,697 $335,000
Q2 2018 Aug 10, 2018	SELL	$26.84 - $34.32 $12,614 - $16,130	-470 Reduced 5.15%	8,656 $283,000
Q4 2017 Feb 12, 2018	SELL	$24.79 - $29.8 $28,979 - $34,836	-1,169 Reduced 11.36%	9,126 $226,000
Q3 2017 Nov 02, 2017	BUY	$26.26 - $29.17 $270,346 - $300,305	10,295	10,295 $300,000

1,539

1.19B

6.79M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Smith, Salley & Associates, based on Form 13F filings with the SEC.

Stay updated on Smith, Salley & Associates with notifications on news.